Hidradenitis Suppurativa and Skin Cancer

Note: This article is for educational purposes only and is not a substitute for diagnosis, treatment, or personalized medical advice from a licensed clinician.

Hidradenitis suppurativa, or HS, is already a lot. It brings painful lumps, drainage, tunnels under the skin, scarring, flare-ups that never seem to check your calendar first, and the kind of discomfort that can make even getting dressed feel like a negotiation. So when people hear that HS may be linked to skin cancer, the reaction is usually immediate and understandable: Wait, what now?

The good news is that HS does not mean you are destined to develop skin cancer. The better news is that the skin cancer concern tied to HS is rare. But it is also real enough to take seriously, especially in people with severe, long-standing disease. That is why this topic deserves a clear, calm, no-panic explanation.

In most cases, the skin cancer discussion around HS centers on squamous cell carcinoma (SCC), not melanoma and not the more common sun-related skin changes people usually picture after too many summers without sunscreen. In HS, the concern is different. The risk tends to be linked to years of chronic inflammation, nonhealing wounds, recurrent drainage, and heavy scar tissue, often in areas such as the buttocks, groin, or around the anus. In other words, this is less about one unlucky sunburn and more about skin that has been stuck in battle mode for far too long.

What Is Hidradenitis Suppurativa, Exactly?

HS is a chronic inflammatory skin disease that usually shows up where skin rubs together, such as the armpits, groin, inner thighs, under the breasts, buttocks, and perianal area. It can start as deep, tender bumps that may burst, drain, and return. Over time, repeated inflammation can lead to abscesses, sinus tracts or tunnels, thick scarring, pain, odor, and restricted movement.

That alone is enough to affect daily life. HS can also carry a heavy emotional burden. People often delay care because the condition appears in intimate areas, causes embarrassment, or gets mistaken for boils, infections, or “just bad skin.” Unfortunately, delayed treatment can allow inflammation to smolder for years, and chronic inflammation is a terrible houseguest. It never leaves quietly.

Does HS Cause Skin Cancer?

The careful answer is this: HS does not automatically cause skin cancer, but long-standing HS can increase the risk of developing squamous cell carcinoma in affected skin. This is considered an uncommon complication, yet it is one clinicians watch for because it can be serious when it happens.

Squamous cell carcinoma usually develops on sun-exposed skin like the face, ears, neck, and hands. With HS, however, SCC may appear in less expected places, particularly in chronic, scarred, nonhealing lesions of the gluteal, groin, or perianal regions. That difference matters. It means a suspicious lesion might hide in an area a person rarely sees clearly, may feel too embarrassed to show, or may assume is “just my HS acting up again.”

And that is where trouble can start. When SCC arises in chronic HS tissue, it may be diagnosed later than typical sun-related skin cancers. Some reports also suggest it can behave aggressively. So while the risk is rare, the need for vigilance is not.

Why Squamous Cell Carcinoma Is the Main Concern

Squamous cells are flat cells found in the upper layers of the skin. SCC develops when these cells begin growing abnormally. In the general population, sun exposure is a major cause. In HS, the more likely setup is repeated injury, inflammation, tissue breakdown, and scarring over many years. Chronic wounds are not ideal environments for healthy skin repair. When the body has to rebuild the same damaged area again and again, mistakes in cell growth can happen.

Think of it like patching the same pothole every week. Eventually, the road stops behaving like a road and starts behaving like a structural problem.

Who May Be at Higher Risk?

Researchers have identified several patterns that seem to show up more often when SCC develops in the setting of HS. None of these are guarantees, but they can help doctors decide when a lesion deserves closer attention.

• Long disease duration: The risk appears higher in people who have had HS for many years, especially severe disease that has been active for a long time.
• Severe HS: Extensive scarring, tunneling, and chronic open lesions raise more concern than mild, occasional nodules.
• Gluteal or perianal involvement: Lesions on the buttocks, groin, or around the anus are often highlighted in the medical literature.
• Smoking: Smoking is strongly associated with HS and may also play a role in the cancers that develop in chronic HS lesions.
• Delayed evaluation: When a changing lesion is assumed to be “just another flare,” diagnosis may come later than it should.

Some studies and reviews have also explored the possible role of human papillomavirus, or HPV, in certain cases, particularly in anogenital disease. That does not mean HPV is the explanation for every cancer risk in HS, but it is one reason specialists may look at the whole clinical picture rather than one sore in isolation.

Warning Signs That Deserve Prompt Medical Attention

One of the hardest parts of spotting skin cancer in HS is that HS already causes sores, drainage, pain, swelling, and scarring. In other words, the disease is noisy. That can make it harder to recognize when something is behaving differently.

Still, certain changes should push the pause button and prompt a medical visit:

• A lesion that does not heal or keeps getting worse instead of cycling through your usual pattern
• A sore that bleeds easily, develops a crust, or repeatedly opens again
• A new hard, raised, wart-like, or scaly growth inside an area of chronic HS
• A scarred area that begins to look or feel different from your typical flares
• Rapid enlargement, increased firmness, or a deeper ulcer-like appearance
• Pain that feels new, persistent, or clearly out of proportion to your usual HS symptoms

A simple rule helps: if a lesion has changed character, lasted longer than your normal flare pattern, or just seems off, get it checked. Your skin is not supposed to become a mystery series.

How Doctors Tell the Difference

Doctors start with a skin exam and a careful history. They will want to know how long the area has been present, how it has changed, whether it bleeds, whether it heals at all, and whether it feels different from your usual HS lesions. They may also ask about smoking, prior procedures, scarring, and symptoms such as weight loss or swollen lymph nodes if cancer becomes a stronger concern.

But here is the key point: a biopsy is the only way to know for sure whether a suspicious lesion is skin cancer. Looking at a lesion, even by an experienced clinician, can raise suspicion. It cannot confirm the diagnosis with certainty. Tissue has to be examined under a microscope.

If SCC is diagnosed, further evaluation may include imaging, lymph node assessment, or referral to specialists depending on the size, depth, and location of the tumor. That sounds intimidating, and yes, it can be. But it is also the path to a real plan instead of anxious guessing.

Treatment: Two Problems, Two Tracks

When HS and skin cancer overlap, treatment usually works on two tracks at once: controlling the underlying HS and treating the cancer itself.

Treating HS

HS treatment may include topical or oral antibiotics, steroid injections, hormonal approaches in selected patients, biologic therapy, pain control, wound care, laser-based approaches, and surgery to remove chronically diseased tissue. Lifestyle measures matter too, especially smoking cessation and weight management when appropriate. No, these are not magical cure buttons. But they can reduce ongoing inflammation, lower flare frequency, and make the skin less trapped in a cycle of damage.

This matters because allowing severe HS to continue unchecked is not good for comfort, mobility, or long-term skin health. Chronic inflammation is not a hobby. It is a medical problem that deserves active management.

Treating Squamous Cell Carcinoma

For many squamous cell skin cancers, surgery is the main treatment. Depending on the location and extent, this may involve standard excision, Mohs surgery in selected cases, or wider surgical removal when disease is advanced or intertwined with extensive scarred tissue. Some patients may also need radiation therapy, especially if the tumor is high-risk or cannot be fully managed with surgery alone.

For advanced SCC that cannot be cured with surgery or radiation, immunotherapy may be an option. This is usually managed by oncology specialists. The exact plan depends on the cancer’s behavior, the patient’s overall health, and the complexity of the underlying HS.

The big takeaway is simple: the earlier SCC is found, the more treatment choices are usually available, and the better the odds of controlling it before it grows deeper or spreads.

How to Protect Yourself If You Have HS

You cannot eliminate every risk, but you can absolutely lower the odds of delayed diagnosis and give your skin a fighting chance.

• See a dermatologist regularly if you have moderate or severe HS, especially with chronic scarring or perianal disease.
• Track lesions that behave differently from your usual flares. Photos can help if a change is subtle over time.
• Do not ignore nonhealing wounds, especially in long-standing scarred areas.
• Ask directly about biopsy if a lesion keeps changing, bleeding, enlarging, or refusing to heal.
• Quit smoking if you smoke. Easier said than done, absolutely. Still worth saying because smoking is tied to worse HS and may raise concern in this cancer pathway too.
• Stick with treatment for HS instead of resigning yourself to “this is just how my skin is.” Early control can matter.
• Take mental health seriously. Anxiety, depression, isolation, and body-image distress are common in HS. Support is not optional fluff. It is part of care.

The Bottom Line

Most people with hidradenitis suppurativa will not develop skin cancer. That point deserves bold, underlined, flashing-marquee energy. But severe, long-standing HS can rarely lead to squamous cell carcinoma in chronically inflamed, scarred, nonhealing skin. Because HS lesions can already look dramatic, a cancerous change can be easy to miss unless both patient and clinician stay alert.

If you live with HS, the best approach is not panic. It is partnership. Know your baseline. Notice what changes. Get stubborn lesions evaluated. Ask for a biopsy when something does not fit the usual pattern. Treat HS proactively. And remember that early detection is not just a slogan. In this setting, it can make a very real difference.

Your skin has been through enough. It deserves attention before a warning sign becomes a crisis.

Experiences Related to Hidradenitis Suppurativa and Skin Cancer

For many people, the experience of living with HS already feels like carrying a private emergency that nobody else can see. The pain can be sharp, the drainage can be embarrassing, and the timing of flare-ups can seem almost sarcastic. Workdays, dates, exercise, sleep, road trips, and even sitting comfortably can all be affected. So when the subject of skin cancer enters the conversation, it often lands with a strange mix of fear and exhaustion. Patients are not just scared of cancer. They are tired of one more thing to worry about.

A common real-world experience is normalizing the abnormal. Someone may live with recurring boils and draining tunnels for so long that a new wound does not feel new anymore. A sore that should raise concern gets mentally filed under “same old HS.” This is especially true in areas that are difficult to see or emotionally hard to talk about, such as the groin, buttocks, or perianal region. People often wait because they are embarrassed, because past appointments were frustrating, or because they assume the doctor will simply tell them to lose weight, stop smoking, and try not to offend their skin. Again.

Another common experience is the emotional toll of uncertainty. HS itself can already cause anxiety, depression, isolation, and low self-confidence. Add the possibility of skin cancer, and every persistent sore can start to feel loaded with meaning. Some patients become hypervigilant and worry that every flare is malignant. Others go the opposite direction and avoid looking at all. Both reactions make sense. Neither is ideal. What helps most is often a clinician who explains what changes are expected in HS and what changes deserve biopsy.

People who do end up needing evaluation for suspected SCC often describe a mix of dread and relief. Dread, because no one wants to hear the word cancer. Relief, because after years of vague symptoms, someone is finally taking the lesion seriously instead of dismissing it as “just inflammation.” A biopsy can be emotionally intense, but it also replaces guesswork with information. And information, while not always comforting, is usually more useful than fear.

There is also a practical side to the experience. Wound care takes time. Dressing changes cost money. Sitting, walking, exercising, and intimacy may all become more complicated. If surgery is needed, recovery can be physically and emotionally demanding. Patients often need support not only from dermatology or oncology, but also from family, partners, wound-care nurses, mental health professionals, and sometimes smoking-cessation programs or pain specialists. In other words, this is not just a skin issue. It can become a whole-life issue.

Still, many people find that being monitored closely gives them a sense of control. Learning what their “usual HS” looks like helps them spot when something is different. Keeping appointments, asking direct questions, and speaking up about changes can turn fear into action. That may be the most important lived experience of all: not that HS makes people powerless, but that knowledge, follow-up, and timely care can help them protect themselves in a situation that once felt impossible to read.